Clinical Trial Update: Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Sunitinib Malate after stereotactic radiosurgery in patients with newly diagnosed brain metastases; the study was terminated but result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Cancer

Drugs mentioned

• Sunitinib malate (sunitinib malate)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Cognitive/Functional Effects, Metastatic Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-10-01